Thieler Law Corp, member of the Investor Attorney Network, is investigating whether certain officers and directors of American Renal Associates Holdings (NYSE: ARA) violated securities laws in connection with certain financial statements.
The investigation seeks to discover if possible claims on behalf of purchasers of the securities of American Renal Associates Holdings (NYSE: ARA) concerning whether a series of statements by American Renal Associates Holdings regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
On March 8, 2019, the Company revealed it would delay the filing of its earnings report for the fiscal year ended December 31, 2018, as it continues to examine reserve computations and other accounting practices that may have an impact on the company’s accounts receivable and revenue for fiscal year 2018, as well as fiscal years 2014 to 2017.
Following this news, NYSE: ARA share price fell by more than 16%, closing at $10.46 on March 8, 2019.
Based in Beverly, Massachusetts, and founded in 1999 American Renal Associates Holdings operates as a dialysis services provider in the United States.
If you purchased shares of American Renal Associates Holdings (NYSE: ARA) on or before March 8, 2019, you should contact Thieler Law Corp at mail@thielerlaw.com or call +1 (619) 377 - 4324.
Thieler Law Corp purchases advertisements on search engines, social media sites and other websites. If you send us information, note that does not create an attorney-client relationship with the firm. Materials are provided for informational purposes only and do not constitute legal advice. We are only licensed to practice law in Germany. We are neither licensed nor qualified to render advice on US Federal or State law.
Thieler Law Corp
2534 State Street - Suite 406,
San Diego, CA 92101
by
email: mail@thielerlaw.com
or
telephone at +1 (619) 377 - 4324
or
visit our website http://www.thielerlaw.com/
or
Facsimile: +1 (619) 785 – 3185
